Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

January 29, 2022

Study Completion Date

January 29, 2022

Conditions
Intrusive ThoughtPsychological TraumaInflammatory ResponsePhysiological Stress
Interventions
DRUG

Dexmedetomidine

Volunteers receive a single dose of dexmedetomidine sublingually at scheduled bedrest in the sleep laboratory

DRUG

Gamma-Hydroxybutyrate

Volunteers receive a single oral dose of gamma-hydroxybutyrate at scheduled bedrest in the sleep laboratory

DRUG

Placebo

Volunteers receive an oral (saline) or sublingual (orodispersible tablet) at scheduled bedrest in the sleep laboratory

BEHAVIORAL

Experimental Model Trauma Film

Each volunteer views experimental model trauma film before scheduled bedrest in the sleep laboratory. This video is ca. 15 minutes in duration and is composed of short (a few seconds to a few minutes) individual and unrelated scenes of violent death and injury of varying description. Six versions of the film without re-occurring scenes will be presented in balanced order across drug order conditions.

Trial Locations (1)

8057

University of Zurich, Zurich

All Listed Sponsors
lead

Psychiatric University Hospital, Zurich

OTHER

NCT04508166 - Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder | Biotech Hunter | Biotech Hunter